Rona Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Rona Therapeutics's total funding is $93M.
Employee Data
- Rona Therapeutics has 15 Employees.
- Rona Therapeutics grew their employee count by 25% last year.
Rona Therapeutics's People
| Name | Title | Email/Phone |
|---|
Rona Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 7 | 75% | N/A | N/A |
#2 | N/A | 8 | 0% | N/A | N/A |
#3 | N/A | 5 | -17% | N/A | N/A |
#4 | N/A | 7 | 17% | N/A | N/A |
#5 | N/A | 16 | -6% | $200M | N/A |
#6 | N/A | 4 | 33% | N/A | N/A |
#7 | N/A | 22 | -12% | $133M | N/A |
#8 | N/A | 5 | 25% | N/A | N/A |
#9 | N/A | 46 | 2% | $146M | N/A |
#10 | N/A | 15 | 25% | $93M | N/A |
What Is Rona Therapeutics?
Rona Therapeutics is a pioneering nucleic acid therapeutics company to discover, develop and deliver transformative modular RNA medicines to treat patients globally.\n\nRona Therapeutics is a global leader in nucleic acid innovative drug platform company, specializing in the treatment of metabolic diseases and neurological diseases. Rona Therapeutics is always committed to developing the best and first-in-class siRNA drugs with differentiation and innovation to address unmet needs and improve outcome in cardiovascular diseases, obesity, and MASH. In addition, Rona Therapeutics is unlocking potential of extra-hepatic delivery for neurological disorders and adipose/muscle delivery for various metabolic syndromes.
keywords:N/A
$93M
Total Funding
15
Number of Employees
N/A
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in shanghai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 15 | -6% | N/A |
#2 | $1.9M | 15 | 36% | N/A |
#3 | $1.3M | 15 | 7% | N/A |
#4 | $2.1M | 15 | -12% | N/A |
#5 | N/A | 16 | 7% | N/A |